$3.30
-0.07-2.08%
At Close: -
$3.26
-0.04-1.21%
After Hours: Jul 22, 4:04 PM EDT
15 minutes delayed
Comments
Loading...
Athira Pharma
ATHANASDAQ
Athira Pharma (NASDAQ:ATHA) Stock, Analyst Ratings, Price Targets, Forecasts
Athira Pharma Inc has a consensus price target of $13 based on the ratings of 7 analysts. The high is $33 issued by Berenberg on April 21, 2022. The low is $3 issued by Jefferies on June 23, 2022. The 3 most-recent analyst ratings were released by JMP Securities on June 20, 2024, May 16, 2024, and August 11, 2023, respectively. With an average price target of $19 between JMP Securities, there's an implied 482.82% upside for Athira Pharma Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JMP Securities
Mizuho
BTIG
Stifel
Jefferies
1calculated from analyst ratings
Analyst Ratings for Athira Pharma
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/20/2024 | Buy Now | 482.82% | JMP Securities | Jason Butler | $19 → $19 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 05/16/2024 | Buy Now | 482.82% | JMP Securities | Jason Butler | → $19 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 08/11/2023 | Buy Now | 482.82% | JMP Securities | Jason Butler | $20 → $19 | Maintains | Outperform | Get Alert |
| 05/15/2023 | Buy Now | 53.37% | Mizuho | Graig Suvannavejh | $6 → $5 | Maintains | Buy | Get Alert |
| 03/30/2023 | Buy Now | 206.75% | BTIG | Thomas Shrader | $33 → $10 | Maintains | Buy | Get Alert |
| 03/24/2023 | Buy Now | 513.5% | JMP Securities | Jason Butler | → $20 | Reiterates | → Market Outperform | Get Alert |
| 07/07/2022 | Buy Now | 84.05% | Mizuho | Graig Suvannavejh | → $6 | Initiates | → Buy | Get Alert |
| 06/23/2022 | Buy Now | 53.37% | Stifel | Paul Matteis | $36 → $5 | Downgrade | Buy → Hold | Get Alert |
| 06/23/2022 | Buy Now | — | JMP Securities | Jason Butler | — | Downgrade | Market Outperform → Market Perform | Get Alert |
| 06/23/2022 | Buy Now | -7.98% | Jefferies | Andrew Tsai | $32 → $3 | Downgrade | Buy → Hold | Get Alert |
| 05/10/2022 | Buy Now | 912.27% | BTIG | Thomas Shrader | → $33 | Initiates | → Buy | Get Alert |
| 04/21/2022 | Buy Now | 912.27% | Berenberg | Esther Hong | → $33 | Initiates | → Buy | Get Alert |
| 12/15/2021 | Buy Now | 390.8% | Goldman Sachs | Corinne Jenkins | — | Initiates | → Neutral | Get Alert |
FAQ
What is the target price for Athira Pharma (ATHA) stock?
The latest price target for Athira Pharma (NASDAQ:ATHA) was reported by JMP Securities on June 20, 2024. The analyst firm set a price target for $19.00 expecting ATHA to rise to within 12 months (a possible 482.82% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Athira Pharma (ATHA)?
The latest analyst rating for Athira Pharma (NASDAQ:ATHA) was provided by JMP Securities, and Athira Pharma reiterated their market outperform rating.
When was the last upgrade for Athira Pharma (ATHA)?
There is no last upgrade for Athira Pharma
When was the last downgrade for Athira Pharma (ATHA)?
The last downgrade for Athira Pharma Inc happened on June 23, 2022 when Stifel changed their price target from $36 to $5 for Athira Pharma Inc.
When is the next analyst rating going to be posted or updated for Athira Pharma (ATHA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Athira Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Athira Pharma was filed on June 20, 2024 so you should expect the next rating to be made available sometime around June 20, 2025.
Is the Analyst Rating Athira Pharma (ATHA) correct?
While ratings are subjective and will change, the latest Athira Pharma (ATHA) rating was a reiterated with a price target of $19.00 to $19.00. The current price Athira Pharma (ATHA) is trading at is $3.26, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.